Calling all pot farmers: Uncle Sam is looking to buy.
An arm of the National Institutes of Health dedicated to researching drug abuse and addiction “intends” to solicit proposals from those who can “harvest, process, analyze, store and distribute” cannabis, according to a listing posted Tuesday night on a federal government website.
A successful bidder must possess a “secure and video monitored outdoor facility” capable of growing and processing 12 acres of marijuana, a 1,000-sq.-ft. (minimum) greenhouse to test the plants under controlled conditions, and “demonstrate the availability” of a vault approved by the Drug Enforcement Administration (DEA) and the Food and Drug Administration to maintain between 400 and 700 kg of pot stock, extract and cigarettes.
Back-up plans in case of emergency required.
The NIH’s National Institute on Drug Abuse (NIDA) is looking for growers who have the capability to develop plants with altered versions of tetrahydrocannabinol (THC), the main psychoactive component of pot, and cannabidiol (CBD), which is known for its medicinal properties. NIDA “anticipates” awarding a one-year contract with four one-year options, according to the posting. The vendor would also have to register with the DEA to research, manufacture and distribute cannabis.
NIDA spokeswoman Shirley Simson said the agency was simply starting a new bidding competition since its existing marijuana-farm contract is set to expire next year. The original solicitation for that contract was issued in 2009.
There are 18 states that have decriminalized pot, 23 states with laws allowing access to medical marijuana, and two states — Colorado and Washington — that have legalized the drug for recreational purposes. Federal law still classifies marijuana as a drug on par with heroin, acid and ecstasy.
— With reporting by Mark Thompson
More Must-Reads from TIME
- Why Trump’s Message Worked on Latino Men
- What Trump’s Win Could Mean for Housing
- The 100 Must-Read Books of 2024
- Sleep Doctors Share the 1 Tip That’s Changed Their Lives
- Column: Let’s Bring Back Romance
- What It’s Like to Have Long COVID As a Kid
- FX’s Say Nothing Is the Must-Watch Political Thriller of 2024
- Merle Bombardieri Is Helping People Make the Baby Decision
Contact us at letters@time.com